Volume : 09, Issue : 12, December – 2022
Title:
71.A SYSTEMATIC REVIEW OF THE RELATIONSHIP BETWEEN QUITTING SMOKING AND THE RISK OF TYPE 2 DIABETES
Authors :
Sameeha AFallatah, Hoda Jehad Abousada, Mohammed Adel Alminee, Hatim Abdulali Alshaikh, Dalia Hassan Bahassan, Ghada Meshall almahyawi, Hassan Saad Alasmari, Raghad Nasser Almehmadi, Ruqeeya Ali Alshaikhnasser, Yazn Mohammed Hakami, Saeed Saad Alshahrani, Alwaleed Ali Alkiyadi, Mohammed Khalid Alharbi, Lamya Omar Abusarir and Abdullah Atallah Alenezi
Abstract :
Background: Tobacco misuse has not been universally acknowledged as a modifiable risk factor in diabetes preventive or screening methods, despite mounting data revealing substantial epidemiological and mechanistic connections between smoking, hyperglycemia, and the development of type 2 diabetes.
Purpose: A growing number of research on the effect of smoking cessation on the development of type 2 diabetes mellitus. The goal of this systematic review was to search the available evidence on the impact of smoking cessation and risk for type 2 diabetes mellitus.
Methods: We searched PubMed, Embase, and Scopus (January 1995–October 2022) for prospective observational studies that evaluated the effects smoking and smoking cessation as risk factors for type 2 diabetes mellitus.
Results: Type 2 diabetes risk was increased by a factor of 1.37 (95% CI: 1.33 to 1.42) for current smokers, 1.14 (1.10 to 1.18) for ex-smokers, and 1.22 (1.10 to 1.35) for passive smokers, compared to those who had never smoked (7 studies). The associations persisted across all subgroups, and a dose-response relation was discovered between current smoking and diabetes risk, with the RRs (95% CIs) for light, moderate, and heavy smokers, compared with never smokers, being 1.21 (1.10-1.33), 1.34 (1.27-1.41), and 1.57 (1.47-1.66), respectively. If there is a causal relationship between smoking and diabetes, we calculated that 10% in men and 2% in women of all instances of type 2 diabetes globally (about 25 million) may be attributed to smoking. The pooled RR (95% CI) from 10 studies showed that recent ex-smokers (within 5 years) had a lower risk of relapse than never smokers, while long-term ex-smokers (within 10 years) had a lower risk of relapse than current smokers.
Conclusion: Both active and passive smoking are strongly connected with higher risks of type 2 diabetes. The risk of diabetes is higher among recent ex-smokers, although it lowers significantly with time.
Cite This Article:
Please cite this article in press Sameeha AFallatah et al, A Systematic Review Of The Relationship Between Quitting Smoking And The Risk Of Type 2 Diabetes.., Indo Am. J. P. Sci, 2022; 09(12).
Number of Downloads : 10
References:
2. US Department of Health and Human Services. The Health Consequences of Smoking-50 Years of Progress A report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
3. Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2007;298:2654–64.
4. World Health Organization. [Accessed January 12, 2023]; http://www.who.int/topics/diabetes_mellitus/en/
5. The Health Consequences of Smoking-50 Years of Progress: A Report of the Surgeon General. Atlanta (GA): 2014.
6. World Health Organization. [Accessed January 12, 2023];Global Report on Diabetes. http://www.who.int/diabetes/global-report/en/
7. Auerbach S, Filer D, Reif D, Walker V, Holloway AC, Schlezinger J, et al. Prioritizing Environmental Chemicals for Obesity and Diabetes Outcomes Research: A Screening Approach Using ToxCast High-Throughput Data. Environmental health perspectives. 2016;124:1141–54.
8. Saeed AA. Association of tobacco products use and diabetes mellitus-results of a national survey among adults in saudi arabia. Balkan medical journal. 2012;29:247–51.
9. Wang Y, Ji J, Liu YJ, Deng X, He QQ. Passive smoking and risk of type 2 diabetes: a meta-analysis of prospective cohort studies. PLoS One. 2013;8:e69915.
10. Sun K, Liu D, Wang C, Ren M, Yang C, Yan L. Passive smoke exposure and risk of diabetes: a meta-analysis of prospective studies. Endocrine. 2014;47:421–7.
11. Wei X, E M, Yu S. A meta-analysis of passive smoking and risk of developing Type 2 Diabetes Mellitus. Diabetes Res Clin Pract. 2015;107:9–14.
12. Rimm EB, Chan J, Stampfer MJ, Colditz GA, Willett WC. Prospective study of cigarette smoking, alcohol use, and the risk of diabetes in men. BMJ. 1995;310:555–9.
13. Wannamethee SG, Shaper AG, Perry IJ. Smoking as a modifiable risk factor for type 2 diabetes in middle-aged men. Diabetes Care. 2001;24:1590–5.
14. Will JC, Galuska DA, Ford ES, Mokdad A, Calle EE. Cigarette smoking and diabetes mellitus: evidence of a positive association from a large prospective cohort study. Int J Epidemiol. 2001;30:540–6.
15. Hur NW, Kim HC, Nam CM, Jee SH, Lee HC, Suh I. Smoking cessation and risk of type 2 diabetes mellitus: Korea Medical Insurance Corporation Study. Eur J Cardiovasc Prev Rehabil. 2007;14:244–9.
16. Yeh HC, Duncan BB, Schmidt MI, Wang NY, Brancati FL. Smoking, smoking cessation, and risk for type 2 diabetes mellitus: a cohort study. Ann Intern Med. 2010;152:10–7.
17. Zhang L, Curhan GC, Hu FB, Rimm EB, Forman JP. Association between passive and active smoking and incident type 2 diabetes in women. Diabetes Care. 2011;34:892–7.
18. Morimoto A, Ohno Y, Tatsumi Y, et al. Impact of smoking cessation on incidence of diabetes mellitus among overweight or normal-weight Japanese men. Diabetes Res Clin Pract. 2012;96:407–13.
19. Oba S, Noda M, Waki K, et al. Smoking cessation increases short-term risk of type 2 diabetes irrespective of weight gain: the Japan Public Health Center-Based Prospective Study. PLoS One. 2012;7:e17061.
20. Luo J, Rossouw J, Tong E, et al. Smoking and diabetes: does the increased risk ever go away? Am J Epidemiol. 2013;178:937–45.
21. Spijkerman AM, van der AD, Nilsson PM, et al. Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations. Diabetes Care. 2014;37:3164–71.
22. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ. 2006;332:1064–9.
23. Sugimori H, Miyakawa M, Yoshida K, et al. Health risk assessment for diabetes mellitus based on longitudinal analysis of MHTS database. J Med Syst. 1998;22:27–32.
24. Akbaraly TN, Fontbonne A, Favier A, Berr C. Plasma carotenoids and onset of dysglycemia in an elderly population: results of the Epidemiology of Vascular Ageing Study. Diabetes Care. 2008;31:1355–9.
25. Fagerberg B, Kellis D, Bergstrom G, Behre CJ. Adiponectin in relation to insulin sensitivity and insulin secretion in the development of type 2 diabetes: a prospective study in 64-year-old women. J Intern Med. 2011;269:636–43.
26. Hayashino Y, Fukuhara S, Okamura T, et al. A prospective study of passive smoking and risk of diabetes in a cohort of workers: the High-Risk and Population Strategy for Occupational Health Promotion (HIPOP-OHP) study. Diabetes Care. 2008;31:732–4.
27. Kowall B, Rathmann W, Strassburger K, et al. Association of passive and active smoking with incident type 2 diabetes mellitus in the elderly population: the KORA S4/F4 cohort study. Eur J Epidemiol. 2010;25:393–402.
28. Hunt KJ, Hansis-Diarte A, Shipman K, Korte JE, Fowler SP, Stern MP. Impact of parental smoking on diabetes, hypertension and the metabolic syndrome in adult men and women in the San Antonio Heart Study. Diabetologia. 2006;49:2291–8.
29. Ko KP, Min H, Ahn Y, et al. A prospective study investigating the association between environmental tobacco smoke exposure and the incidence of type 2 diabetes in never smokers. Ann Epidemiol. 2011;21:42–7.
30. Lajous M, Tondeur L, Fagherazzi G, de Lauzon-Guillain B, Boutron-Ruaualt MC, Clavel-Chapelon F. Childhood and adult secondhand smoke and type 2 diabetes in women. Diabetes Care. 2013;36:2720–5.
31. Oberg M, Jaakkola MS, Woodward A, Peruga A, Pruss-Ustün A. Worldwide burden of disease from exposure to second-hand smoke: a retrospective analysis of data from 192 countries. Lancet. 2011;377:139–46.
32. Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87:801–9.
33. Aubin HJ, Farley A, Lycett D, Lahmek P, Aveyard P. Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ. 2012;345:e4439.
34. Attvall S, Fowelin J, Lager I, Von Schenck H, Smith U. Smoking induces insulin resistance-a potential link with the insulin resistance syndrome. J Intern Med. 1993;233:327–32.
35. Eliasson B, Attvall S, Taskinen MR, Smith U. Smoking cessation improves insulin sensitivity in healthy middle-aged men. Eur J Clin Invest. 1997;27:450–6.
36. Bergman BC, Perreault L, Hunerdosse D, et al. Novel and reversible mechanisms of smoking-induced insulin resistance in humans. Diabetes. 2012;61:3156–66.
37. Maeda K, Noguchi Y, Fukui T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: a meta-analysis. Prev Med. 2003;37:283–90.
38. Balkau B, Vierron E, Vernay M, et al. The impact of 3-year changes in lifestyle habits on metabolic syndrome parameters: the D.E.S.I. R Study. Eur J Cardiovasc Prev Rehabil. 2006;13:334–40.
39. Stadler M, Tomann L, Storka A, et al. Effects of smoking cessation on beta-cell function, insulin sensitivity, body weight, and appetite. Eur J Endocrinol. 2014;170:219–27.
40. Lycett D, Nichols L, Ryan R, et al. The association between smoking cessation and glyceamic controls in patients with type 2 diabetes: a THIN database cohort study. Lancet Diabetes Endocrinol. 2015;3:423–30.
41. Clair C, Rigotti NA, Porneala B, et al. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. JAMA. 2013;309:1014–21.
42. Luo J, Rossouw J, Margolis KL. Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes. JAMA. 2013;310:94–6.
43. Pirie K, Peto R, Reeves GK, Green J, Beral V. The 21st century hazards of smoking and benefits of stopping: a prospective study of one million women in the UK. Lancet. 2013;381:133–41.
44. Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341–50.
45. Ng M, Freeman MK, Fleming TD, et al. Smoking prevalence and cigarette consumption in 187 countries, 1980-2012. JAMA. 2014;311:183–92.
46. World Health Organization. WHO report on the global tobacco epidemic, 2013. Geneva, Switzerland: World Health Organization; 2013. [accessed January 12, 2023]. http://www.who.int/tobacco/global_report/2013/en/
47. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2224–60.